Zhujiang Hospital of Southern Medical University

date:2025-07-08

Zhujiang Hospital of Southern Medical University

Zhujiang Hospital of Southern Medical University: A Benchmark Hospital for Complex and Critical Care and Smart Healthcare in the Guangdong-Hong Kong-Macao Greater Bay Area

I. Hospital Overview

Zhujiang Hospital of Southern Medical University (referred to as “Zhujiang Hospital”) is a Grade A tertiary general hospital directly under the National Health Commission and affiliated with Southern Medical University. It is a modern research-oriented hospital integrating medical care, teaching, scientific research, prevention, and health preservation, with core specialties in “neurology, cardiovascular diseases, and precision oncology.” The hospital traces its origins to the PLA Tenth Rear Hospital established in 1947. It was renamed “Zhujiang Hospital of the First Military Medical University” in 1978. In 2004, it transitioned with the First Military Medical University to become a directly affiliated hospital of Southern Medical University. In 2021, it was selected as a cultivation unit for the National Regional Medical Center (South China). It has now emerged as one of the hospitals with the strongest medical resource outreach and leading smart capabilities in the Guangdong-Hong Kong-Macao Greater Bay Area.

Currently, the hospital operates under a “one hospital, two campuses” structure: the main campus (Haizhu Campus) is located in the core area of Haizhu District, Guangzhou, while the Nansha Campus (National Regional Medical Center construction project) serves the Nansha New Area of the Guangdong-Hong Kong-Macao Greater Bay Area. The main campus operates over 2,500 beds, handles more than 4 million outpatient and emergency visits annually, discharges over 100,000 patients yearly, and performs over 60,000 surgeries (with complex Grade III and IV procedures accounting for over 50%). Its specialized departments—including Neurosurgery, Cardiovascular Medicine, and the Cancer Center—rank among the top in South China for patient volume.

The hospital employs over 4,500 staff members, including more than 700 senior-level experts. These include top scholars such as dual-appointed academicians, recipients of the National Science Fund for Distinguished Young Scholars, and Changjiang Scholars, as well as leading figures in their fields, such as chairpersons and vice-chairpersons of various professional committees under the Chinese Medical Association. The team has collectively received over 10 national awards, including the National Science and Technology Progress Award and the Ho Leung Ho Lee Prize. It has led or participated in more than 600 international multicenter clinical trials and developed over 50 international/national diagnostic and treatment guidelines. The hospital ranks among the top 30 global institutions in medical research output and clinical influence.

II. Hospital Technical Advantages: Focusing on Complex and Critical Cases, Leading Smart Healthcare Innovation

Zhujiang Hospital, with its core mission of “resolving complex cases and advancing medical progress,” has established nationally leading technical strengths in neurology, cardiovascular diseases, precision oncology, critical care, and minimally invasive surgery:

1. Neurology: The “Brain Care Flagship” of South China

• Neurosurgery performs over 3,000 procedures annually, including high-complexity interventions such as cerebral vascular disease endovascular treatments (aneurysm embolization/thrombectomy), epilepsy surgery (precision resection of epileptogenic foci), and molecular-targeted therapy for gliomas. Its success rate for complex aneurysm endovascular procedures exceeds 95% (world-leading).

• Neurology achieves nationally top-tier standards in Parkinson's disease DBS (deep brain stimulation) therapy, acute cerebral infarction thrombolysis/thrombectomy (DNT time reduced to under 20 minutes), and spinal cord lesion diagnosis/treatment;

• Leads the National Key R&D Program “Application of Brain-Computer Interface Technology in Brain Injury Rehabilitation,” with its “Intelligent Rehabilitation Robot” already deployed clinically.

2. Cardiovascular Diseases: A “Technical Benchmark” in Minimally Invasive Interventions

• Cardiovascular Medicine performs over 8,000 interventional procedures annually, including complex coronary interventions (left main coronary artery lesions, chronic total occlusions), arrhythmias (atrial fibrillation radiofrequency ablation), and structural heart diseases (TAVI, mitral valve clipping). Annual transcatheter aortic valve implantation (TAVI) procedures exceed 200 (ranking among the top three in South China).

• Cardiac and Great Vessel Surgery performs high-complexity procedures like the “Sun procedure” for aortic dissection and minimally invasive valve replacement, maintaining a surgical mortality rate below 1% (compared to the international standard of 2%);

• Equipped with a tri-modal imaging system combining Intravascular Ultrasound (IVUS), Optical Coherence Tomography (OCT), and Fractional Flow Reserve (FFR) for precise coronary lesion assessment.

3. Precision Oncology: A Hub for Comprehensive Care

• The Oncology Center treats over 25,000 patients annually, offering a full spectrum of therapies including surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy. Annual Da Vinci robotic surgeries exceed 300 cases (gastrointestinal and urological cancers);

• The Radiation Oncology Department features the world's most advanced technologies: Tomotherapy (TOMO) and CyberKnife, enabling precision tumor irradiation with sub-millimeter accuracy (<1mm);

• Leading the clinical trial “Liquid Biopsy (ctDNA)-Guided Personalized Cancer Therapy,” which has increased targeted therapy efficacy by 30% and achieved nationally leading clinical application rates for post-drug-resistance solutions.

4. Critical Care: Life-Saving Pioneers on the Frontlines

• The Intensive Care Unit (ICU) operates over 150 beds, equipped with world-leading ECMO (12 units), CRRT (40 units), and high-end ventilators (150 units);

• Established four emergency green channels for "Chest Pain/Stroke/ Trauma/Sepsis" emergency green channels, reducing D2B time (door-to-balloon) for acute myocardial infarction to under 50 minutes, with stroke thrombolysis rates ranking among the highest in South China;

• Pioneered a precision assessment system combining critical care ultrasound, hemodynamic monitoring, and AI-driven early warning, achieving over 70% success rate in rescuing multi-organ failure patients (compared to the international average of 55%).

5. Minimally Invasive Surgery: A “South China Model” in Endoscopy and Robotics

• General Surgery performs laparoscopic gastrectomy/colorectal cancer resection (over 90% minimally invasive rate) and robot-assisted thyroidectomy (0.5cm incision);

• Urology conducts percutaneous nephrolithotomy and robot-assisted radical prostatectomy, achieving an over 95% success rate in complex cases;

• Thoracic Surgery performs single-port thoracoscopic lung cancer resection and minimally invasive esophageal cancer surgery, reducing postoperative pain scores by 50%.

III. Hospital's Leading Specialties: National Key Disciplines at the Forefront, Multiple Fields with International Accreditation

Zhujiang Hospital boasts 6 National Key Clinical Specialties (Neurosurgery, Cardiovascular Medicine, Cancer Center, Orthopedics, Critical Care Medicine, Dermatology) and 12 Guangdong Provincial Key Clinical Specialties (Neurology, Urology, Obstetrics and Gynecology, Pediatrics, Emergency Medicine, etc.), forming a disciplinary system characterized by “strong core specialties and comprehensive supporting disciplines”:

• Neurosurgery: Ranked among China's top 15 for eight consecutive years in Fudan University's Hospital Specialty Rankings; designated as the South China Branch of the National Medical Center for Neurological Diseases; led the development of China's Interventional Diagnosis and Treatment Guidelines for Cerebrovascular Diseases;

• Cardiology: National Key Clinical Specialty; designated as the South China Branch of the National Quality Control Center for Interventional Diagnosis and Treatment of Coronary Heart Disease; performs over 3,000 PCI (Percutaneous Coronary Intervention) procedures annually;

• Oncology Center: Southern Branch of the National Cancer Center; leading institution of the South China Precision Cancer Treatment Alliance; implements a multidisciplinary team (MDT) approach covering over 90% of cases;

• Orthopedics: Leading institution of the South China Spine Surgery Alliance; pioneers innovative techniques including 3D-printed personalized prosthetic replacement and robot-assisted spinal surgery; achieves 90% success rate in complex spinal deformity correction;

• Critical Care Medicine: South China Branch of the National Critical Care Quality Control Center, leading the national “14th Five-Year Plan” key R&D project “Precision Treatment for Sepsis”;

• Dermatology: National Clinical Key Specialty, achieving nationally leading standards in treating complex conditions like psoriasis, vitiligo, and bullous skin diseases, with annual outpatient visits exceeding 300,000.

IV. Departmental Structure: Comprehensive Health Management for All Population Needs

Beyond its specialized strengths, the hospital maintains a full complement of departments covering Internal Medicine (Cardiovascular, Respiratory, Gastroenterology, Nephrology, etc.), Surgery (General Surgery, Orthopedics, Neurosurgery, Cardiothoracic Surgery, etc.), Obstetrics and Gynecology, Pediatrics, Emergency Medicine, Critical Care Medicine, Dermatology, Ophthalmology, Otolaryngology, Stomatology, Traditional Chinese Medicine, Rehabilitation Medicine, Oncology, and more than 50 other clinical departments. Additionally, over 10 medical technology platforms—including the Pathology Center, Imaging Center, Laboratory Medicine Center, and Blood Transfusion Department—provide comprehensive medical services spanning prevention, diagnosis, and rehabilitation.

V. Medical Equipment: World-Class Technology Enabling Precision Diagnosis and Treatment

The hospital is equipped with globally leading medical devices to support precise diagnosis and treatment of complex and critical conditions:

• Surgical Robots: Da Vinci Xi Surgical System (4 units), Surgical Sharp Single-Port Laparoscopic Robot (1 unit), supporting complex laparoscopic surgeries in gastroenterology, urology, gynecology, etc.;

• Imaging Equipment: GE SIGNA PET/MR (first in South China), 3.0T Prisma MRI, Dual-Source CT, Digital Flat Panel Gastrointestinal Machine;

• Life Support Systems: ECMO (12 units), CRRT (40 units), High-End Ventilators (150 units), Extracorporeal Shock Wave Lithotripsy Machine;

• Interventional Therapy Equipment: Philips Ingenia 3.0T DSA, Tomotherapy System, Radiofrequency Ablation System;

• Endoscopy and Pathology Equipment: Olympus 290 Electronic Gastrointestinal Endoscopes (with NBI functionality), Zeiss Lumera Microscope, Digital Pathology Slide Scanning System;

• Rehabilitation equipment: Intelligent rehabilitation robots (upper/lower limb), virtual reality (VR) rehabilitation systems, transcranial magnetic stimulation (TMS) devices.

VI. International Patient Services: Comprehensive Bilingual Support for a Global Healthcare Experience

As a leading provider of international medical services in South China, Zhujiang Hospital offers seamless “one-stop” convenience for international patients:

• Language Services: Multilingual medical staff fluent in English, Japanese, Korean, Arabic, and professional medical translators (including clinical terminology) cover the entire process from consultation and examination to surgery;

• International Medical Department: Dedicated area offering premium outpatient services (by appointment) and VIP wards (including private rooms and suites), with direct billing for international insurance (covering over 60 major insurers from the US, Europe, Southeast Asia, etc.);

• Convenience Services: Visa extension assistance, multilingual patient guides (department maps, examination instructions), religious dietary customization (halal, kosher, vegetarian), cross-border shuttle transfers (via international medical transport partners);

• Remote Consultations: Collaborations with global leaders, including Mayo Clinic (USA), Johns Hopkins Hospital (USA), and The Royal Marsden (UK), enable cross-border remote case discussions and second medical opinions.

VII. International Patient Testimonials: “Technical Excellence, Thoughtful Service”

• Mr. John (58, brain aneurysm), New York, USA: “The neurosurgery team successfully removed my brain aneurysm via endovascular surgery—no craniotomy required! The doctor thoroughly explained each step and associated risks in English. Postoperative recovery guidance was highly professional. I am deeply grateful.”

• Ms. Lin (42, breast cancer), Singapore: “The Oncology Center designed a personalized ‘surgery + immunotherapy’ plan for me. All follow-up indicators are now normal. The International Medical Department's translator resolved my communication challenges—truly thoughtful.”

• Mr. Surya (65, acute myocardial infarction), Jakarta, Indonesia: " Through the chest pain green channel, I completed an ECG and thrombolysis within 15 minutes. I'm recovering well now! Nurses teach me cardiac rehab exercises in English daily—it's very warm."

VIII. Contact Information, Address, and Transportation Routes

1. Main Campus (Haizhu Campus)

• Address: No. 253, Middle Gongye Avenue, Haizhu District, Guangzhou (near Yangan Station, Guangfo Line)

• Contact: 020-61643888 (Main Switchboard); International Medical Department: 020-61643200

Transportation Routes:

• Subway: Exit B at Yangan Station (Guangfo Line), 5-minute walk

• Bus: “Zhujiang Hospital Station” (B9, 180, 263, 765, etc.)

• By Car: Underground parking available (fee applies). Navigate to “Zhujiang Hospital of Southern Medical University Main Campus”.

2. Nansha Campus (National Regional Medical Center)

• Address: 25 Huanshi Avenue West, Wanqingsha Town, Nansha District, Guangzhou (near Metro Line 18 Wanqingsha Station)

• Contact: 020-84981200 (Main Switchboard)

• Transportation: Exit A from Wanqingsha Station (Metro Line 18), 10-minute walk; Bus “Wanqingsha Zhujiang Hospital Station” (Nansha Line 5, Nansha Line 15, etc.).

Zhujiang Hospital of Southern Medical University steadfastly upholds its motto of “Compassionate Care and Skillful Practice, Upholding Integrity and Embracing Innovation.” Leveraging cutting-edge medical technology, an internationalized service system, and precision diagnostics for complex and critical conditions, the hospital consistently delivers high-quality, compassionate healthcare to patients worldwide. It actively contributes to the advancement of “Healthy China” and “Healthy Bay Area” initiatives.

Document dated 2025-09-12 09:23 Modify